MUMBAI India’s largest drugmaker, Sun Pharmaceutical Industries, plans to ask U.S. regulators by the middle of this year to re-inspect a plant in Gujarat after they criticised manufacturing standards there, Sun’s founder said. 416 more words
Tags » Pharma
“Over the past two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself. 114 more words
February 3, 2016
According to a recent study in the Journal of the National Cancer Institute. 714 more words
Indian Patent Office Rejected Compulsory License Application (C.L.A. No.1 of 2015) for "Saxagliptin" Filed by Lee Pharma Ltd.
In an order dated 19th January 2016, the Controller of Patents rejected the compulsory license application of Hyderabad based drug maker Lee Pharma Ltd. to manufacture generic version of AstraZeneca’s anti-diabetic drug Saxagliptin. 748 more words
Dr. Reddy’s announced on Monday that its US subsidiary, Promius PharmaTM, LLC, U.S. has received approval for Sernivo™ Spray, 0.05% from the U.S. Food and Drug Administration (FDA). 364 more words